Melkani, Girish C.
- University of Alabama at Birmingham · Pathology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,084
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$2.2M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#3,084
By linked amount among FY2023 PIs
Earliest Year Loaded
2011
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Melkani, Girish C. as a PI. Multi-PI records show the full award amount for context.
- 1RF1NS133378-01RF1Contact PIPromoting circadian rhythms to optimize gut-to-brain signaling for Alzheimer's diseaseUniversity of Alabama at Birmingham · Pathology (NIH department code)$1.9Maward amount
- 5R01AG065992-06R01Contact PIMolecular basis of circadian rhythms disruptions linked cardiometabolic disorders and their mitigation using dietary interventionUniversity of Alabama at Birmingham · Pathology (NIH department code)$371.3Kaward amount
Award organization
Organizations that administered FY2023 awards listing Melkani, Girish C. as a PI.
FY2023 award administered by University of Alabama at Birmingham (AL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardUniversity of Alabama at Birmingham
- 2015$500K Cumulative Funding
- 2015R01 Grant Holder
- 2019$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #3084
- 2023Entered Top 25% NationallyRanked #3084